Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.

NCT: NCT07086534 · RECRUITING

NCT IDNCT07086534
StatusRECRUITING
Start Date2026-03-26
Completion2031-05-31

Brief Summary

To confirm the effectiveness and safety of the GeminiOne Transcatheter Mitral Valve Repair System for the treatment of severe, symptomatic mitral regurgitation.

Frequently Asked Questions

What is A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.?

A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR. is a clinical trial registered under NCT07086534. Current status: RECRUITING.

What is the status of NCT07086534?

The current status of NCT07086534 (A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.) is: RECRUITING.

When did A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR. start?

A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR. started on 2026-03-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑